U.S. · HEALTH · NOV 9, 4:33 PM ET
FDA warns of rare 'eye stroke' risk from GLP-1 drugs
Reported by 14 outlets in the past day, including The Hill, NBC News, Euronews.
1What happened
The Food and Drug Administration (FDA) on Monday required pharmaceutical companies to warn patients and healthcare providers of a potential increased risk of a serious eye condition associated with the use of GLP-1 drugs for weight loss and diabetes. The Hill ↗
2Also reported
The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness. NBC News ↗
Sources
- FDA warns of rare 'eye stroke' risk from GLP-1 drugs ↗The Hill
- FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness ↗NBC News
- US drug watchdog orders new safety warnings for weight-loss drugs over potential risk of vision loss ↗Euronews
- FDA Demands New Blindness Warning For GLP-1 Drugs ↗Gizmodo
- FDA orders warning on GLP-1 drugs, citing rare risk for vision loss ↗FirstWord Pharma